FGF Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy | Cholangiocarcinoma | Urothelial Cancer | Endometrial Cancer | Biliary Tract Cancer |
---|---|---|---|---|
erdafitinib | ||||
pembrolizumab + pemigatinib | ||||
futibatinib | ||||
infigratinib + PD173074 | ||||
sorafenib | ||||
infigratinib | ||||
FGFR inhibitor |